MONICA SPELLMAN: Open Payments
NPI 1568493955 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,650 in 127 payments from 20 companies in 2025. Trend: 2023 $2,263 · 2024 $2,655 · 2025 $2,650
Food & beverage: $2,650
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $332 |
| ABBVIE INC. | 17 | $305 |
| Janssen Biotech, Inc. | 15 | $258 |
| Madrigal Pharmaceuticals | 9 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $213 |
| Ipsen Biopharmaceuticals, Inc | 6 | $165 |
| QOL Medical, LLC | 7 | $159 |
| PFIZER INC. | 6 | $148 |
| Celltrion USA Inc. | 6 | $146 |
| Ardelyx, Inc. | 10 | $145 |
Products named: XIFAXAN, TREMFYA, LINZESS, REZDIFFRA, IQIRVO, Sucraid, VEGZELMA, IBSRELA.
Industry payments across VA — which companies pay providers there.
